We are live on
!
Find out more
Trevi Therapeutics
TRVI
TRVI
198 hedge funds and large institutions have $1.61B invested in Trevi Therapeutics in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
96% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $5.67M
71% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 24
8% more funds holding
Funds holding: 184 → 198 (+14)
3.45% more ownership
Funds ownership: 101.65% → 105.09% (+3.4%)
5% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 62
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
1% less capital invested
Capital invested by funds: $1.63B → $1.61B (-$17M)
Holders
198
Holders Change
+14
Holders Change %
+7.61%
% of All Funds
2.44%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
41
Increased
65
Reduced
62
Closed
24
Calls
$11.1M
Puts
$5.67M
Net Calls
+$5.44M
Net Calls Change
+$7.59M
Top Buyers
| 1 |
VPC
Vestal Point Capital
New York
|
+$24.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$20M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.7M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$9.92M |
Top Sellers
| 1 |
OCA
Octagon Capital Advisors
New York
|
-$14.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.5M |
| 3 |
O
OrbiMed
New York
|
-$8.24M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$6.88M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$6.78M |
